Physician profile
James Stillerman
NPI 1699881573
$16,204.33
in general payments reported to CMS, 2019-2025
28 companies · $1,353 in 2025
The $1,353 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,940 · 2020: $778 · 2021: $3,775 · 2022: $1,483 · 2023: $1,868 · 2024: $5,007 · 2025: $1,353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,431 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,885 · Consulting Fee: $875 · Travel and Lodging: $37.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,431.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,885.00 |
| Consulting Fee | $875.00 |
| Travel and Lodging | $37.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $5,061.96 | 2021-2025 | Hydrofera Blue Ready - Border, Hydrofera Blue, Cutimed Sorbact |
| Mimedx Group, INC. | $3,270.28 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $2,440.50 | 2019-2024 | |
| Organogenesis INC. | $1,240.55 | 2019-2025 | Apligraf, Puraply, Affinity |
| Misonix INC | $602.60 | 2019-2021 | |
| Bsn Medical INC | $602.18 | 2024-2025 | |
| Smith+Nephew, INC. | $462.95 | 2019-2025 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Lifenet Health | $396.24 | 2025 | Theragenesis Wound Matrix |
| Next Science LLC | $386.39 | 2022-2023 | Surgx, Xperience, Blastx |
| Molnlycke Health Care US, LLC | $285.49 | 2019-2024 | Mepilex Border Sacrum, Mepilex Border Flex, Mepilex Lite |
| Integra Lifesciences Corporation | $249.66 | 2019-2022 | |
| Urgo Medical North America, LLC | $237.48 | 2022-2024 | Urgoclean Ag |
| Baxter Healthcare | $211.74 | 2025 | |
| Vaporox, INC. | $119.60 | 2024 | Vht-200 Wound Treatment System |
| Musculoskeletal Transplant Foundation INC. | $113.21 | 2022-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $99.28 | 2019-2025 | Topical Oxygen Chamber For Extremities |
| Convatec INC. | $82.69 | 2021-2025 | |
| Solventum Corporation | $55.48 | 2024-2025 | Activ.A.C. |
| Medline Industries LP | $46.10 | 2019-2023 | |
| Paratek Pharmaceuticals, INC. | $43.33 | 2024 | Nuzyra |
| Hartmann USA, INC. | $39.45 | 2025 | Zetuvit Plus 10x10 P10 |
| Kci USA, INC. | $32.73 | 2020 | |
| Polymedics Innovations INC. | $24.54 | 2025 | |
| Ets Wound Care LLC | $22.87 | 2023 | |
| Lilly USA, LLC | $21.04 | 2020 | |
| 3m Company | $20.42 | 2019 | |
| Tactile Systems Technology INC | $19.29 | 2019 | |
| Bioventus LLC | $16.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Stillerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.